FDG-PET/CT in cancers of the head and neck: What is the definition of whole body scanning?

Molecular Imaging and Biology

Volumn 13, Issue 2, 2011, Pages 362-367

  Iagaru, Andrei ^a   Mittra, Erik S ^a   Gambhir, Sanjiv Sam ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; CT; FDG; Head and neck; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADRENAL GLAND; ADULT; AGED; ARTICLE; BONE METASTASIS; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 79955965422     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0343-8     Document Type: Article

References (15)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225-249
2. Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2(9):683-693
3. Facey K, Bradbury I, Laking G, Payne E (2007) Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 11(44):iii-iv, xi-267
4. Hillner BE, Siegel BA, Liu D et al (2008) Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol 26 (13):2155-2161
5. Zafra M, Ayala F, Gonzalez-Billalabeitia E et al (2008) Impact of whole-body (18)F-FDG PET on diagnostic and therapeutic management of medical oncology patients. Eur J Cancer 44(12):1678-1683
6. Zeitouni AG, Yamamoto YL, Black M, Gjedde A (1994) Functional imaging of head and neck tumors using positron emission tomography. J Otolaryngol 23(2):77-80 (Pubitemid 24153338)
7. Agarwal V, BFt B, Johnson JT (2008) Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 41(1):23-49, v
8. Senft A, de Bree R, Hoekstra OS et al (2008) Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial. Radiother Oncol 87(2):221-229
9. Kim SY, Roh JL, Yeo NK et al (2007) Combined 18F-fluorodeoxyglucose- positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol 18 (10):1698-1703 (Pubitemid 47506258)
10. Ishimori T, Patel PV, Wahl RL (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46(5):752-757
11. King AD, Ma BB, Yau YY et al (2008) The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 81(964):291-298 (Pubitemid 351702957)
12. Gil Z, Even-Sapir E, Margalit N, Fliss DM (2007) Integrated PET/CT system for staging and surveillance of skull base tumors. Head Neck 29 (6):537-545 (Pubitemid 47324769)
13. Kim MR, Roh JL, Kim JS et al (2007) Utility of (18)F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx. Eur J Surg Oncol 33(5):633-638 (Pubitemid 46746539)
14. Murakami R, Uozumi H, Hirai T et al (2007) Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 68(2):377-382 (Pubitemid 46694156)
15. Segall GM (2008) A new paradigm to increase utilization of PET/CT. J Nucl Med 49(6):53N-56N